{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:40:06Z","timestamp":1761100806253},"reference-count":39,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.thromres.2005.10.010","type":"journal-article","created":{"date-parts":[[2005,12,6]],"date-time":"2005-12-06T12:20:52Z","timestamp":1133871652000},"page":"611-618","source":"Crossref","is-referenced-by-count":12,"title":["Veno-occlusive disease prophylaxis with fresh frozen plasma and heparin in bone marrow transplantation"],"prefix":"10.1016","volume":"118","author":[{"given":"Ioannis","family":"Batsis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evangelia","family":"Yannaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panayotis","family":"Kaloyannidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioanna","family":"Sakellari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos","family":"Smias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Georgoulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athanasios","family":"Fassas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Achilles","family":"Anagnostopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2005.10.010_bib1","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/hep.1840040121","article-title":"Veno-occlusive disease of the liver after marrow transplantation: diagnosis, incidence, and predisposing factors","volume":"4","author":"McDonald","year":"1984","journal-title":"Hepatology"},{"key":"10.1016\/j.thromres.2005.10.010_bib2","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1182\/blood.V85.11.3005.bloodjournal85113005","article-title":"The syndrome of hepatic veno-occlusive disease after bone marrow transplantation","volume":"85","author":"Bearman","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2005.10.010_bib3","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1046\/j.1365-2141.1999.01680.x","article-title":"The pathology, diagnosis and treatment of hepatic veno-occlusive disease: current status and novel approaches","volume":"107","author":"Richardson","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2005.10.010_bib4","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/hep.1840190515","article-title":"Veno-occlusive disease of the liver after bone marrow transplantation: histological correlates of clinical signs and symptoms","volume":"19","author":"Shulman","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.thromres.2005.10.010_bib5","doi-asserted-by":"crossref","first-page":"255","DOI":"10.7326\/0003-4819-118-4-199302150-00003","article-title":"Veno-occlusive disease of the liver and multi-organ failure after bone marrow transplantation: a cohort study of 355 patients","volume":"118","author":"Mc Donald","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.thromres.2005.10.010_bib6","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/00007890-198712000-00011","article-title":"Veno-occlusive disease of the liver following bone marrow transplantation","volume":"44","author":"Jones","year":"1987","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.thromres.2005.10.010_bib7","first-page":"3599","article-title":"Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European group for blood and marrow transplantation","volume":"92","author":"Carreras","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2005.10.010_bib8","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1182\/blood.V81.12.3458.3458","article-title":"Naturally occurring anticoagulants and bone marrow transplantation: plasma Protein C predicts development of veno-occlusive disease of the liver","volume":"81","author":"Faioni","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2005.10.010_bib9","first-page":"253","article-title":"Hypercoagulability in patients undergoing autologous or allogeneic BMT for hematological malignancies","volume":"12","author":"Catani","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.thromres.2005.10.010_bib10","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/sj.bmt.1702624","article-title":"Predictive markers for hepatic veno-occlusive disease after hematopoietic stem cell transplantation in adults: a prospective single center study","volume":"26","author":"Tanikawa","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.thromres.2005.10.010_bib11","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/sj.bmt.1701445","article-title":"Relevance of proteins C and S, antithrombin III, von Willebrand factor, and factor VIII for the development of hepatic veno-occlusive disease in patients undergoing allogeneic bone marrow transplantation: a prospective study","volume":"22","author":"Lee","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.thromres.2005.10.010_bib12","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0049-3848(00)00269-3","article-title":"Is veno-occlusive disease a specific syndrome or the exacerbation of physiopathologic hemostatic changes in hematopoietic stem cell transplantation?","volume":"99","author":"Villalon","year":"2000","journal-title":"Thromb Res"},{"issue":"2","key":"10.1016\/j.thromres.2005.10.010_bib13","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/sj.bmt.1703618","article-title":"Septic shock and multiple organ failure after hematopoietic stem cell transplantation: treatment with recombinant human activated protein C","volume":"30","author":"Pastores","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.thromres.2005.10.010_bib14","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.bbmt.2004.01.002","article-title":"Prevention of veno-occlusive disease with defibrotide after allogeneic stem cell transplantation","volume":"10","author":"Chalandon","year":"2004","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.thromres.2005.10.010_bib15","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1182\/blood.V79.11.2834.bloodjournal79112834","article-title":"Prevention of hepatic veno-occlusive disease after bone marrow transplantation by continuous infusion of low-dose heparin: a prospective randomized trial","volume":"79","author":"Attal","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2005.10.010_bib16","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/sj.bmt.1702854","article-title":"Retrospective multivariate analysis of hepatic veno-occlusive disease after blood or marrow transplantation: possible beneficial use of low molecular weight heparin","volume":"27","author":"Simon","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.thromres.2005.10.010_bib17","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1365-2141.1990.tb02583.x","article-title":"Use of prostaglandin E1 for prevention of liver veno-occlusive disease in leukaemic patients treated by allogeneic bone marrow transplantation","volume":"74","author":"Gluckman","year":"1990","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2005.10.010_bib18","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1182\/blood.V82.3.732.732","article-title":"Prevention of regimen-related toxicities after bone marrow transplantation by pentoxyfylline: a prospective, randomized trial","volume":"82","author":"Attal","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2005.10.010_bib19","doi-asserted-by":"crossref","first-page":"975","DOI":"10.7326\/0003-4819-128-12_Part_1-199806150-00002","article-title":"Ursodiol prophylaxis against hepatic complications of allogeneic bone marrow transplantation: a randomized, double-blind, placebo-controlled trial","volume":"128","author":"Essell","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.thromres.2005.10.010_bib20","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1182\/blood.V80.8.2149.2149","article-title":"Prevention of veno-occlusive disease of the liver after bone marrow transplantation: heparin or no heparin?","volume":"80","author":"Cahn","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2005.10.010_bib21","first-page":"185","article-title":"Phase II trial of heparin prophylaxis for veno-occlusive disease of the liver in children undergoing bone marrow transplantation","volume":"18","author":"Rosenthal","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.thromres.2005.10.010_bib22","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/sj.bmt.1704087","article-title":"Low molecular weight heparin for the prevention of hepatic veno-occlusive disease after hematopoietic stem cell transplantation: a prospective phase II study","volume":"31","author":"Forrest","year":"2003","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"10.1016\/j.thromres.2005.10.010_bib23","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/00007890-199604150-00014","article-title":"Low molecular weight heparin for the prevention of veno-occlusive disease of the liver in bone marrow transplantation patients","volume":"61","author":"Or","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.thromres.2005.10.010_bib24","first-page":"40716","article-title":"A pilot study of continuous infusion heparin for the prevention of hepatic veno-occlusive disease after bone marrow transplantation","volume":"5","author":"Bearman","year":"1990","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.thromres.2005.10.010_bib25","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1600-0609.1991.tb01859.x","article-title":"Prophylactic heparin does not prevent liver veno-occlusive disease after following autologous bone marrow transplantation","volume":"47","author":"Marsa-Vila","year":"1991","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.thromres.2005.10.010_bib26","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2141.2004.04868.x","article-title":"Efficacy of standard dose and 30 ml\/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients","volume":"125","author":"Chowdhury","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2005.10.010_bib27","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/00000542-199603000-00032","article-title":"Practice guidelines for blood component therapy","volume":"84","author":"American society of Anesthesiologists Task Force on Blood Component Therapy","year":"1996","journal-title":"Anesthesiology"},{"key":"10.1016\/j.thromres.2005.10.010_bib28","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1182\/blood.V79.10.2784.2784","article-title":"Marked increase in veno-occlussive disease of the liver associated with methotrexate use for graft-vs.-host disease prophylaxis in patients receiving busulfan\/cyclophosphamide","volume":"79","author":"Essell","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2005.10.010_bib29","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0301-472X(03)00070-5","article-title":"Positive selection for CD34+ reduces the incidence and severity of veno-occlusive disease of the liver after HLA-identical sibling allogeneic peripheral blood stem cell transplantation","volume":"31","author":"Moscardo","year":"2003","journal-title":"Exp Hematol"},{"issue":"1","key":"10.1016\/j.thromres.2005.10.010_bib30","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.bmt.1704069","article-title":"Incidence, survival and risk factors for the development of veno-occlusive disease in pediatric hematopoietic stem cell transplant recipients","volume":"32","author":"Barker","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.thromres.2005.10.010_bib31","first-page":"135","article-title":"Risk factors for hepatic veno-occlusive disease after high-dose busulfan-containing regimens followed by autologous bone marrow transplantation: a study in 136 children","volume":"10","author":"Meresse","year":"1992","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.thromres.2005.10.010_bib32","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1046\/j.1365-2141.2000.02475.x","article-title":"Defibrotide for the treatment of hepatic veno-occlusive disease: results of the European compassionate-use study","volume":"111","author":"Chopra","year":"2000","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.thromres.2005.10.010_bib33","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/sj.bmt.1704329","article-title":"Defibrotide in the treatment of children with veno-occlusive disease (VOD): a retrospective multicentre study demonstrates therapeutic efficacy upon early intervention","volume":"33","author":"Corbacioglu","year":"2004","journal-title":"Bone Marrow Transplant"},{"issue":"13","key":"10.1016\/j.thromres.2005.10.010_bib34","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1182\/blood-2002-04-1216","article-title":"Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response without significant toxicity in a high-risk population and factors predictive of outcome","volume":"100","author":"Richardson","year":"2002","journal-title":"Blood"},{"issue":"16","key":"10.1016\/j.thromres.2005.10.010_bib35","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1001\/jama.274.16.1289","article-title":"Multiple organ dysfunction syndrome in bone marrow transplantation","volume":"274","author":"Haire","year":"1995","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.thromres.2005.10.010_bib36","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/sj.bmt.1700985","article-title":"Antithrombin-III for the treatment of chemotherapy-induced organ dysfunction following bone marrow transplantation","volume":"20","author":"Morris","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.thromres.2005.10.010_bib37","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1365-2141.2003.04415.x","article-title":"The pathophysiology of variant Creutzfeldt-Jacob disease: the hypotheses behind concerns for blood components and products","volume":"122","author":"Burthem","year":"2003","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.thromres.2005.10.010_bib38","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/j.1537-2995.2004.03400.x","article-title":"Long-term survival after blood transfusion: a population based-study in the North of England","volume":"44","author":"Wallis","year":"2004","journal-title":"Transfusion"},{"issue":"Suppl 1","key":"10.1016\/j.thromres.2005.10.010_bib39","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0049-3848(02)00145-7","article-title":"Manufacture and composition of fresh frozen plasma and virus-inactivated therapeutic plasma preparations: correlation between composition and therapeutic efficacy","volume":"107","author":"Hellstern","year":"2002","journal-title":"Thromb Res"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384805004275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384805004275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,11]],"date-time":"2020-04-11T11:10:38Z","timestamp":1586603438000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384805004275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S0049384805004275"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2005.10.010","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}